Safety is a key factor in any medical treatment, and semaglutide has been extensively studied in large-scale clinical trials
They are a bit heavy on the updates but I'd rather have more communication than less
At first, Wegovy was FDA-approved for chronic weight management when paired with exercise, dietary modifications, and increased physical activity in patients with obesity (body mass index 30 kg/m or more) and overweight (BMI 27 kg/m or more) with at least one weight-related health condition such as heart diseases, high blood pressure (hypertension), high cholesterol levels, type 2 diabetes, and sleep apnea
Conversely, pediatric patients may have special needle requirements based on their size and development stage
2023) confirmed that TRZ mitigates memory and learning impairment by reducing BIR and A accumulation in the hippocampus of diabetic rats
Who should avoid using Tirzepatide for weight loss